BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies
| Date | 6th, Oct 2023 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.